TABLE 3—
Mortality Disadvantage for US Women by Cause of Death (Scenario 2): United States and 7 European Countries, 1989–2003
| All-Cause Mortality |
Cancer Mortality |
Mortality From Cardiovascular Disease |
Mortality From Other Diseases |
Mortality From External Causes |
||||||
| Countries | Observed US Mortality Disadvantagea (95% CI) | Expected US Mortality Disadvantageb (95% CI) | Observed US Mortality Disadvantagea (95% CI) | Expected US Mortality Disadvantageb (95% CI) | Observed US Mortality Disadvantagea (95% CI) | Expected US Mortality Disadvantageb (95% CI) | Observed US Mortality Disadvantagea (95% CI) | Expected US Mortality Disadvantageb (95% CI) | Observed US Mortality Disadvantagea (95% CI) | Expected US Mortality Disadvantageb (95% CI) |
| Belgium | 40 (23, 58) | −148 (−157, −139) | 27 (18, 37) | −16 (−37, 4) | 9 (0, 17) | −60 (−86, −34) | 19 (11, 28) | −47 (−69, −26) | −15 (−17, −12) | −25 (−29, −20) |
| Denmark | −154 (−171, −136) | −250 (−262, −239) | −79 (−88, −70) | −104 (−126, −81) | 8 (−1, 17) | −21 (−52, 11) | −67 (−75, −58) | −101 (−127, −75) | −16 (−18, −13) | −25 (−29, −20) |
| Finland | 73 (56, 91) | −67 (−77, −57) | 55 (45, 64) | 13 (−8, 33) | −23 (−32, −14) | −65 (−94, −35) | 64 (55, 72) | 12 (−12, 35) | −22 (−25, −19) | −26 (−32, −21) |
| Francec | 316 (299, 333) | 175 (160, 189) | NA | NA | NA | NA | NA | NA | NA | NA |
| Norway | 111 (93, 128) | 47 (37, 58) | 14 (4, 23) | −10 (−33, 12) | 33 (24, 42) | 25 (−8, 59) | 64 (56, 73) | 41 (14, 68) | 0 (−3, 2) | −9 (−14, −4) |
| Sweden | 219 (202, 236) | 175 (165, 185) | 44 (34, 53) | 27 (4, 50) | 73 (64, 81) | 68 (34, 102) | 106 (97, 114) | 89 (60, 117) | −3 (−5, 0) | −9 (−14, −3) |
| Switzerland | 217 (199, 234) | 48 (39, 57) | 48 (39, 58) | 10 (−11, 31) | 93 (84, 101) | 44 (15, 72) | 81 (73, 90) | 9 (−12, 30) | −5 (−8, −2) | −15 (−19, −10) |
Note. CI = confidence interval; NA = not available.
a
The US mortality disadvantage is the absolute difference between the US standardized mortality rate and that of each Western European country (in deaths per 100 000 person-years).
b
The impact of differences in educational inequalities in mortality was assessed by estimating the US mortality disadvantage (expected) in a scenario in which the educational disparities in mortality in the US were replaced by those in each Western European country.
c
Cause-specific mortality data are not available for the French population.